China’s genetic testing and medical diagnostic service provider GensKey has secured nearly 100 million yuan ($14 million) in a Series B round of financing from SB China Capital, Shanghai Lin Chong Investment Management, and Juyuan Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
